Thrombosis is clearly the most common cause of death in the United States (see Table 1). About two million individuals die each year from an arterial or venous thrombosis or the consequences thereof. About 80% to 90% of all causes of thrombosis can now be defined with respect to cause. Of these, over 50% of all patients harbor a congenital or acquired blood coagulation protein or platelet defect which caused the thrombotic event. It is obviously of major importance to define those individuals harboring such a defect, as this allows (1) appropriate antithrombotic therapy to decrease risks of recurrence (2) determine length of time the patient must remain on therapy for secondary prevention and (3) allow for testing of family members in those harboring a blood coagulation protein or platelet defect which is hereditary (about 50% of all coagulation and platelet defects mentioned above). These and common clinical defects leading to thrombosis are discussed later and found in Table 2. Aside from mortality, significant additional morbidity occurs from both arterial or venous thrombotic events, including, but not limited to paralysis (non-fatal thrombotic stroke), cardiac disability (repeated coronary events), loss of vision (retinal vascular thrombosis) and fetal wastage syndrome (placental vascular thrombosis), stasis ulcers and other manifestations of post-phlebitic syndrome (recurrent DVT), etc. |
|||||
Dallas Thrombosis Hemostasis Clinical Center MISSION: Specializing in all clinical aspects of the diagnosis of causes and specific treatment of Thrombosis, including deep vein thrombosis, pulmonary embolus, recurrent miscarriage (placental thrombosis), transient cerebral ischemia (TIA), and stroke (cerebrovascular thrombosis) retinal vascular thrombosis and coronary artery thrombosis. The Center also specializes in the diagnosis and treatment of bleeding disorders, including such problems as hemophilia, von Willebrands disease, circulating anticoagulants, platelet function defects, low platelet counts, vascular bleeding problems, and others. For More information contact: www.thrombosis.net |
ThromboCare Laboratories, L.P. MISSION: ThromboCare, unlike many other Coagulation Laboratories is a Doctor (all thrombosis specialists)-managed and driven specialized laboratory specializing in aiding other physicians to diagnose and manage their patients with thrombosis, bleeding or medical vascular disorders. All doctors associated with ThromboCare are board certified in Thrombosis Hemostasis and Vascular Medicine and not only oversee and continuously add new clinically useful procedures to the Laboratory Menu, but are also available for immediate telephone consultation to other physicians and laboratory scientists to discuss problems with the diagnosis and management of patients with these disorders. For More information contact: www.ThromboCare.com |
||||